Advicenne (ALDVI) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.099x

Based on the latest financial reports, Advicenne (ALDVI) has a cash flow conversion efficiency ratio of -0.099x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.89 Million ≈ $2.20 Million USD) by net assets (€-19.07 Million ≈ $-22.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Advicenne market capitalisation for the company's overall valuation and market capitalisation.

Advicenne - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Advicenne's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Advicenne Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Advicenne ranked by their cash flow conversion efficiency. See Advicenne (ALDVI) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Thunderful Group AB ST:THUNDR	-0.023x
Greencore Group LSE:GNC	0.221x
Ugint Co Ltd KQ:195990	-0.098x
Arrive AI Inc. NASDAQ:ARAI	-1.272x
Glen Burnie Bancorp NASDAQ:GLBZ	0.020x
Winamp Group SA PA:ALPET	N/A
Flour Mills Kepenos S.A. AT:KEPEN	0.322x
Cadrenal Therapeutics, Inc. Common Stock NASDAQ:CVKD	-1.671x

Annual Cash Flow Conversion Efficiency for Advicenne (2015–2024)

The table below shows the annual cash flow conversion efficiency of Advicenne from 2015 to 2024. View Advicenne (ALDVI) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-19.07 Million ≈ $-22.30 Million	€-762.00K ≈ $-890.86K	0.040x	-92.01%
2023-12-31	€-11.97 Million ≈ $-13.99 Million	€-5.99 Million ≈ $-7.00 Million	0.500x	-41.93%
2022-12-31	€-10.62 Million ≈ $-12.41 Million	€-9.15 Million ≈ $-10.69 Million	0.862x	+102.13%
2021-12-31	€309.00K ≈ $361.25K	€-12.53 Million ≈ $-14.64 Million	-40.534x	-1034.15%
2020-12-31	€3.27 Million ≈ $3.83 Million	€-11.69 Million ≈ $-13.67 Million	-3.574x	-538.39%
2019-12-31	€16.92 Million ≈ $19.79 Million	€-9.47 Million ≈ $-11.08 Million	-0.560x	-62.93%
2018-12-31	€29.63 Million ≈ $34.64 Million	€-10.18 Million ≈ $-11.90 Million	-0.344x	-98.49%
2017-12-31	€33.51 Million ≈ $39.18 Million	€-5.80 Million ≈ $-6.78 Million	-0.173x	-1230.87%
2016-12-31	€-5.15 Million ≈ $-6.02 Million	€67.00K ≈ $78.33K	-0.013x	-100.81%
2015-12-31	€-1.67 Million ≈ $-1.95 Million	€-2.69 Million ≈ $-3.15 Million	1.613x	--

About Advicenne

PA:ALDVI France Biotechnology

Market Cap

$12.95 Million

€11.07 Million EUR

Market Cap Rank

#26482 Global

#442 in France

Share Price

€0.76

Change (1 day)

+10.13%

52-Week Range

€0.69 - €2.21

All Time High

€15.27